About ASMS

About Secretary

The Secretary serves a two-year term. Their duties and responsibilities include:

  1. Is the official ASMS record keeper;
  2. Shall record all votes and minutes of all meetings of the Board of Directors and all general meetings of the Society;
  3. Shall perform such other duties as may be prescribed by the Board of Directors or the President;
  4. Monitors online the balloting results for the annual Board election;
  5. Coordinates meetings and proceedings of the Committee for selection of the Award for Distinguished Contribution and the Biemann Medal;
  6. Along with Past President, updates By-laws and Board policies documents after each Board meeting.

Return to Board of Directors Election page to learn about other roles and their nominees.

Candidates for Secretary


Jessica E. Prenni

Colorado State University

Candidate Statement
ASMS has been a huge part of my career as a mass spectrometrist, providing an annual opportunity to renew my passion for science and to connect with and expand my network of colleagues and friends. I would be honored for the opportunity to give back by serving on the ASMS board. 

Jessica E. Prenni, B.S. in Chemistry (Southern Oregon University); Ph.D. in Analytical Chemistry (University of Colorado Boulder with Professor Kathy Rowlen); Postdoctoral Fellow (Scripps Research Institute, Dr. Gary Suizdak).  Dr. Prenni is currently an Associate Professor in the Department of Horticulture and Landscape Architecture at Colorado State University, Fort Collins, CO.

Dr. Prenni has over 17 years of experience in biological mass spectrometry and served for over ten years as the Director of the Proteomics and Metabolomics Core Facility at Colorado State University (CSU).  During this time, her group developed novel approaches in metabolomics for analytical methods and data analysis including the RAMClustR algorithm for metabolite clustering and annotation.  The overall theme of her current research is the application of mass spectrometry to address important issues in food/crop safety and quality.  Current projects are focused on the use of mass spectrometry to (1) dissect complex genotype by environment (GxE) interactions, including the microbiome, in plant and animal systems (2) develop novel approaches using ambient ionization for characterization of food quality and authenticity (3) perform sensitive and rapid quantification of drug and chemical residues in food products (4) develop novel methods for metabolomics sample preparation, data acquisition, and informatics.  Her work has results in over 100 peer-reviewed publications and book chapters.

Dr. Prenni has chaired sessions on the application of mass spectrometry at several ASMS conferences and has served on both the ASMS publication and diversity committees.  She routinely participates as a reviewer for the NSF major research instrumentation program, is an active peer manuscript reviewer for multiple journals including JASMS and Analytical Chemistry and is currently an editor for Scientific Reports.  She also co-founded and served as President Elect (2009-2014) and board member (2016-2019) of the Colorado Biological Mass Spectrometry Society.


Birgit Schilling

Buck Institute for Research on Aging

Candidate Statement
By serving on the ASMS Board of Directors, I hope to help advance the knowledge and exchange of scientific ideas for technologies and applications related to mass spectrometry. Specifically, I hope to enhance educational activities for young scientists and early career researchers. For all scientists, I like to encourage topic-focused workshops, user groups, and sharing of technological expertise between scientists, that may even yield formation of collaborative consortia.

Birgit Schilling, M.S./Diploma in chemistry (University of Hamburg, Germany); Ph.D. in chemistry (University of Clausthal, Germany with Professor Dieter Kaufmann); Postdoctoral Fellow (UCSF, San Francisco, CA) with Drs. Al Burlingame and Brad Gibson). Dr. Schilling is currently Associate Professor and Director of the Mass Spectrometry Technology Center at the Buck Institute for Research on Aging, in Novato, CA (San Francisco Bay Area) and Adjunct Professor at the University of Southern California (Los Angeles, CA).

Dr. Schilling uses modern quantitative proteomics technologies, such as data-independent acquisitions (DIA), to investigate mechanisms of aging and diseases. She is interested in translational research that aims towards therapeutic interventions to improve human aging or disease. Her research concerns ‘senescence-derived biomarkers of aging’ with an emphasis on the key roles that the accumulation of senescent cells and, specifically, the secretome and released exosomes play as non-autonomous drivers of aging and age-related diseases. In additional key projects, she investigates the dynamic role of post-translational modifications in metabolic and neurodegenerative diseases, and the remodeling of extracellular matrix in cancer and aging. Technologically, Dr. Schilling has benchmarked quantitative workflows, such as MS1-based, SRM, PRM and DIA methodologies, as part of large international, multi-laboratory studies (e.g., CPTAC and other consortia). Dr. Schilling co-teaches (international) quantitative proteomics courses, including applications of innovative software solutions (Skyline). Her work has resulted in over 125 peer-reviewed publications and book chapters.

Dr. Schilling chaired oral sessions on ‘Protein Quantification’ and ‘Aging’ at ASMS and other conferences. She served as coordinator for the ASMS Interest Group and Workshop on Data-Independent Acquisition and has been an instructor in the ASMS short course on Quantitative Proteomics. In 2021, Dr. Schilling will co-organize the Asilomar Conference on Neurodegenerative Diseases. She participated as an ad hoc reviewer for the ‘Enabling Bioanalytical and Imaging Technologies’ (EBIT) study section (NIH Center for Scientific Review), and currently serves as a standing member of the ‘Neurological Sciences Training’ (NST-2) study section of the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Schilling is also a member of US-HUPO, International HUPO, and Society for Neuroscience. She currently serves on the Editorial Board of Molecular & Cellular Proteomics.